But that’s our role as shareholders to help fund teams/projects
I supported the cap raise at 17c - the purpose of that raise was to advance RP-11/platform to market - was expecting the ramp up of staff.
We help sow into their opportunity to do some really important/exciting science - and PYC/patients has the opportunity to reap rewards/hope if successful.
Worth remembering the probability of success is not affected by the mood of the market/share price, but the determination/ /efforts and quality of output by the team of 70.
But that’s our role as shareholders to help fund teams/projects...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118941 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 183634 | 2 |
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable